PharmaResearch Co., Ltd. (KOSDAQ:214450)
448,000
+5,000 (1.13%)
May 30, 2025, 1:40 PM KST
PharmaResearch Revenue
PharmaResearch had revenue of 116.91B KRW in the quarter ending March 31, 2025, with 56.47% growth. This brings the company's revenue in the last twelve months to 392.31B, up 39.97% year-over-year. In the year 2024, PharmaResearch had annual revenue of 350.12B with 34.14% growth.
Revenue (ttm)
392.31B
Revenue Growth
+39.97%
P/S Ratio
11.73
Revenue / Employee
959.19M
Employees
409
Market Cap
4,602.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 350.12B | 89.10B | 34.14% |
Dec 31, 2023 | 261.01B | 66.25B | 34.02% |
Dec 31, 2022 | 194.76B | 40.68B | 26.40% |
Dec 31, 2021 | 154.08B | 45.34B | 41.69% |
Dec 31, 2020 | 108.75B | 24.87B | 29.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 3.15B |
LigaChem Biosciences | 125.90B |